1.Eating, diet, and nutrition for the treatment of non-alcoholic fatty liver disease
Georg SEMMLER ; Christian DATZ ; Michael TRAUNER
Clinical and Molecular Hepatology 2023;29(Suppl):S244-S260
Nutrition and dietary interventions are a central component in the pathophysiology, but also a cornerstone in the management of patients with non-alcoholic fatty liver disease (NAFLD). Summarizing our rapidly advancing understanding of how our diet influences our metabolism and focusing on specific effects on the liver, we provide a comprehensive overview of dietary concepts to counteract the increasing burden of NAFLD. Specifically, we emphasize the importance of dietary calorie restriction independently of the macronutrient composition together with adherence to a Mediterranean diet low in added fructose and processed meat that seems to exert favorable effects beyond calorie restriction. Also, we discuss intermittent fasting as a type of diet specifically tailored to decrease liver fat content and increase ketogenesis, awaiting future study results in NAFLD. Finally, personalized dietary recommendations could be powerful tools to increase the effectiveness of dietary interventions in patients with NAFLD considering the genetic background and the microbiome, among others.
3.Decreasing systemic inflammation after TIPS: Still hope for the liver: Reply to correspondence on “Insertion of a transjugular intrahepatic portosystemic shunt leads to sustained reversal of systemic inflammation in patients with decompensated liver cirrhosis”
Georg SEMMLER ; Lorenz BALCAR ; Mattias MANDORFER
Clinical and Molecular Hepatology 2025;31(2):e224-e225
4.Treating systemic inflammation by transjugular intrahepatic portosystemic shunt: Editorial on “Insertion of a transjugular intrahepatic portosystemic shunt leads to sustained reversal of systemic inflammation in patients with decompensated liver cirrhosis”
Georg SEMMLER ; Lorenz BALCAR ; Mattias MANDORFER
Clinical and Molecular Hepatology 2025;31(2):615-619
5.Decreasing systemic inflammation after TIPS: Still hope for the liver: Reply to correspondence on “Insertion of a transjugular intrahepatic portosystemic shunt leads to sustained reversal of systemic inflammation in patients with decompensated liver cirrhosis”
Georg SEMMLER ; Lorenz BALCAR ; Mattias MANDORFER
Clinical and Molecular Hepatology 2025;31(2):e224-e225
6.Treating systemic inflammation by transjugular intrahepatic portosystemic shunt: Editorial on “Insertion of a transjugular intrahepatic portosystemic shunt leads to sustained reversal of systemic inflammation in patients with decompensated liver cirrhosis”
Georg SEMMLER ; Lorenz BALCAR ; Mattias MANDORFER
Clinical and Molecular Hepatology 2025;31(2):615-619
7.Decreasing systemic inflammation after TIPS: Still hope for the liver: Reply to correspondence on “Insertion of a transjugular intrahepatic portosystemic shunt leads to sustained reversal of systemic inflammation in patients with decompensated liver cirrhosis”
Georg SEMMLER ; Lorenz BALCAR ; Mattias MANDORFER
Clinical and Molecular Hepatology 2025;31(2):e224-e225
8.Treating systemic inflammation by transjugular intrahepatic portosystemic shunt: Editorial on “Insertion of a transjugular intrahepatic portosystemic shunt leads to sustained reversal of systemic inflammation in patients with decompensated liver cirrhosis”
Georg SEMMLER ; Lorenz BALCAR ; Mattias MANDORFER
Clinical and Molecular Hepatology 2025;31(2):615-619